{"result": "{\n    \"title\": \"Osteoporosis and Sarcoma Community\",\n    \"summary\": \"The community encompasses various medical conditions and treatments related to osteoporosis and sarcoma. Key entities include medications used for treating osteoporosis, symptoms associated with both conditions, and their interrelationships, highlighting the complexity of managing these health issues.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the significant health risks and complications associated with osteoporosis and sarcoma, as well as the potential for severe side effects from treatments.\",\n    \"findings\": [\n        {\n            \"summary\": \"Osteoporosis as a critical health condition\",\n            \"explanation\": \"Osteoporosis is a prevalent medical condition characterized by decreased bone density, leading to an increased risk of fractures and complications. It significantly impacts individuals' health and quality of life, necessitating effective management strategies. The condition is often treated with medications such as Raloxifene, Alendronate, and Zoledronate, which are associated with various side effects, including abdominal pain and anaphylactic shock. The complexity of osteoporosis management is underscored by its association with other conditions, such as back pain and emaciation, which can further complicate treatment outcomes [Data: Entities (431, 449, 450, 445, 787); Relationships (790, 298, 392, 770, 235)]\"\n        },\n        {\n            \"summary\": \"Sarcoma's relationship with various symptoms and treatments\",\n            \"explanation\": \"Sarcoma is a type of cancer that presents various symptoms, including pain, anorexia, and cachexia. It is treated with several compounds, such as Doxorubicin, Etoposide, and Vincristine, which are effective but also associated with significant side effects like abdominal pain and agranulocytosis. The relationship between sarcoma and its symptoms highlights the need for comprehensive treatment approaches that address both the disease and its manifestations. Additionally, the localization of sarcoma in various body parts, including lymph nodes and the pleura, complicates its management and necessitates a multidisciplinary approach [Data: Entities (453, 688, 368, 455, 792); Relationships (390, 283, 552, 794, 306)]\"\n        },\n        {\n            \"summary\": \"Interconnectedness of osteoporosis and sarcoma\",\n            \"explanation\": \"There is a notable interconnectedness between osteoporosis and sarcoma, particularly in how osteoporosis can lead to complications that may exacerbate sarcoma symptoms. For instance, osteoporosis can result in back pain and fractures, which may complicate the clinical picture for patients with sarcoma. This relationship emphasizes the importance of holistic patient care that considers the potential interactions between different medical conditions and their treatments. Understanding these connections can lead to better management strategies and improved patient outcomes [Data: Relationships (392, 298, 373, 552, 770)]\"\n        },\n        {\n            \"summary\": \"Diverse treatment options for osteoporosis\",\n            \"explanation\": \"Osteoporosis is managed through a variety of treatment options, including bisphosphonates like Alendronate and Risedronate, as well as hormonal therapies such as Estrogens and Raloxifene. Each treatment option comes with its own set of potential side effects, which can impact patient adherence and overall health. The choice of treatment must be tailored to the individual, considering factors such as age, gender, and the presence of comorbid conditions. This diversity in treatment underscores the complexity of managing osteoporosis effectively [Data: Entities (431, 449, 450, 445, 787); Relationships (790, 787, 788, 786, 783)]\"\n        },\n        {\n            \"summary\": \"Significant side effects associated with cancer treatments\",\n            \"explanation\": \"The treatments for sarcoma, including compounds like Doxorubicin and Etoposide, are effective but can lead to severe side effects such as agranulocytosis and abdominal pain. These side effects can significantly affect the patient's quality of life and may require additional interventions to manage. Understanding the side effects associated with these treatments is crucial for healthcare providers to ensure comprehensive care and support for patients undergoing treatment for sarcoma [Data: Entities (453, 688, 368, 455, 792); Relationships (390, 283, 552, 794, 306)]\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n431,OSTEOPOROSIS,\"Osteoporosis is a medical condition characterized by a decrease in bone density, which results in an increased risk of fractures and other complications. It is a disease that can significantly impact an individual's health and quality of life. Raloxifene is one of the medications used to treat osteoporosis, helping to manage the condition and reduce the risk of fractures.\",31\n453,SARCOMA,Sarcoma is a type of disease characterized by various symptoms and localizations in the human body.,28\n154,ETOPOSIDE,\"Etoposide is a compound classified as a topoisomerase inhibitor, utilized in the treatment of various types of cancer, including prostate cancer, vaginal cancer, sarcoma, and urinary bladder cancer. This medication is known to have side effects, which may include abdominal pain and agranulocytosis. Etoposide's mechanism of action involves interfering with the DNA replication process, making it effective against these malignancies.\",11\n155,ETHINYL ESTRADIOL,\"Ethinyl Estradiol is a compound classified as an Estrogen Receptor Agonist. It is utilized in various medical contexts, including the treatment of prostate cancer and the palliation of symptoms associated with Polycystic Ovary Syndrome. Additionally, Ethinyl Estradiol is employed in the management of osteoporosis. The compound is known to have several side effects, which may include anxiety, abdominal pain, and breast disorders.\",10\n156,CONJUGATED ESTROGENS,\"Conjugated Estrogens is a compound classified as an Estrogen Receptor Agonist. It is utilized in the treatment of both prostate cancer and osteoporosis. The compound is associated with several side effects, which include acidosis, abdominal cramps, and anaphylactic shock.\",9\n152,EPIRUBICIN,\"Epirubicin is a compound classified as a Topoisomerase Inhibitor, primarily used in the treatment of various types of cancer, including stomach cancer, prostate cancer, and sarcoma. This medication is associated with several side effects, which may include lactic acidosis, agranulocytosis, and abdominal distension. As a versatile treatment option, Epirubicin plays a significant role in oncology, targeting different cancer types while presenting a range of potential adverse effects that require monitoring.\",10\n129,NILUTAMIDE,\"Nilutamide is a compound classified as an androgen receptor antagonist, primarily used in the treatment of prostate cancer. This medication is known to be effective in managing the disease, but it is also associated with several side effects, including abdominal pain and alopecia.\",10\n158,MITOXANTRONE,\"Mitoxantrone is a compound classified as a topoisomerase inhibitor, utilized in the treatment of various types of cancer, including prostate cancer, lymphatic system cancer, and sarcoma. This medication is associated with a range of side effects, which may include anxiety, arrhythmia, abdominal pain, and agranulocytosis. Its role as a topoisomerase inhibitor makes it effective in disrupting the DNA replication process in cancer cells, thereby aiding in the management of these malignancies.\",10\n147,BACK PAIN,\"Back pain is a prevalent condition that can arise from a variety of causes, including injury, muscle strain, or underlying medical conditions. It is commonly associated with osteoporosis, often resulting from fractures or changes in the spine. Additionally, back pain can be a side effect linked to several medical treatments. For instance, it is noted as a side effect of compounds used to palliate or treat Polycystic Ovary Syndrome and is also associated with the use of Isradipine. Furthermore, back pain can occur as a side effect of treatments aimed at alleviating symptoms of Prostate Cancer. In the context of specific medical conditions, back pain is recognized as a symptom of Sarcoma, indicating discomfort in the back region. Overall, back pain is a multifaceted issue that can stem from both medical conditions and the side effects of various treatments.\",3\n449,ALENDRONATE,\"Alendronate is a diphosphonate that treats osteoporosis, with side effects including abdominal pain and asthma.\",1\n450,CALCIUM ACETATE,\"Calcium acetate is a compound that treats osteoporosis, with side effects including arrhythmia and confusion.\",1\n446,CHOLECALCIFEROL,\"Cholecalciferol is a vitamin D compound that treats osteoporosis, promoting calcium absorption.\",1\n432,EMACIATION,\"Emaciation is a severe symptom that may be associated with osteoporosis, reflecting significant weight loss and malnutrition.\",1\n438,EPIPHYSIS,\"The epiphysis is a part of the bone structure that can be affected by osteoporosis, particularly in joint areas.\",1\n451,ESTROPIPATE,\"Estropipate is a compound that treats osteoporosis, with side effects including abdominal cramps and anxiety.\",1\n433,HEMIPLEGIA,\"Hemiplegia is a condition that may occur in severe cases of osteoporosis, leading to paralysis on one side of the body.\",1\n439,HIP,\"The hip is a common site for fractures in individuals with osteoporosis, leading to significant health risks.\",1\n440,HIP JOINT,The hip joint is a critical area where osteoporosis can lead to fractures and mobility issues.,1\n448,IBANDRONATE,\"Ibandronate is a diphosphonate used to treat osteoporosis, associated with side effects like abdominal pain and anxiety.\",1\n442,JAW SKELETON,\"The jaw skeleton is another area where osteoporosis can have effects, particularly in older adults.\",1\n443,LOWER JAW REGION,\"The lower jaw region can be impacted by osteoporosis, affecting dental health and bone integrity.)<|COMPLETE|>The lower jaw region can be impacted by osteoporosis, affecting dental health and bone integrity.\",1\n441,MANDIBLE,\"The mandible is a bone that can be affected by osteoporosis, leading to dental and structural issues.\",1\n434,MENKES KINKY HAIR SYNDROME,Menkes Kinky Hair Syndrome is a genetic disorder that may present symptoms similar to those of osteoporosis.,1\n435,VERTEBRAL COLUMN,\"The vertebral column is a critical area affected by osteoporosis, where fractures can lead to significant complications.\",1\n436,PARATHYROID GLAND,The parathyroid gland is involved in calcium regulation and can be affected by osteoporosis.,1\n437,SCIATIC NERVE,\"The sciatic nerve may be impacted by osteoporosis-related conditions, leading to pain and mobility issues.\",1\n444,OXANDROLONE,Oxandrolone is a compound that can palliate osteoporosis but has several side effects including azoospermia and hirsutism.,1\n445,ZOLEDRONATE,\"Zoledronate is a compound used to treat osteoporosis, associated with side effects like abdominal pain and anaphylactic shock.\",1\n447,RISEDRONATE,\"Risedronate is a diphosphonate compound that treats osteoporosis, with side effects like abdominal pain and anxiety.\",1\n455,THIOTEPA,\"Thiotepa is an alkylating agent utilized in the treatment of various cancers, including Sarcoma and Urinary Bladder Cancer. While it is effective in combating these malignancies, it is associated with side effects such as abdominal pain and agranulocytosis.\",2\n368,VINCRISTINE,\"Vincristine is a compound classified as a vinca alkaloid, primarily used in the treatment of various cancers, including Lymphatic System Cancer and Sarcoma. While it is effective in combating these types of cancer, Vincristine is associated with several side effects, notably abdominal cramps and alopecia.\",2\n454,DACTINOMYCIN,\"Dactinomycin is a compound used to treat Sarcoma, with side effects such as abdominal pain and agranulocytosis.\",1\n457,PLEURA,The pleura is a part of the human body where Sarcoma can localize.,1\n456,STERNUM,The sternum is a part of the human body where Sarcoma can localize.,1\n157,ABIRATERONE,\"Abiraterone is a compound with no specific pharmacologic class mentioned, used to treat prostate cancer, with side effects including arrhythmia and chest pain.\",8\n150,ESTRADIOL,\"Estradiol is a compound classified as an Estrogen Receptor Agonist used to treat prostate cancer, with side effects including abdominal cramps and anaphylactic shock.\",8\n151,PREDNISONE,\"Prednisone is a compound classified as a Corticosteroid Hormone Receptor Agonist used to treat prostate cancer, with side effects including abdominal distension and adrenal insufficiency.\",8\n295,POLYCYSTIC OVARY SYNDROME,\"Polycystic Ovary Syndrome is a disease characterized by various symptoms and localizations in the human body, affecting women's reproductive health.\",6\n310,DESOGESTREL,\"Desogestrel is a compound classified as a Progesterone Congener, used to palliate symptoms of Polycystic Ovary Syndrome.\",1\n308,DROSPIRINONE,\"Drospirenone is a compound classified as a Progesterone Congener, used to palliate symptoms of Polycystic Ovary Syndrome.\",1\n307,LEVONORGESTREL,\"Levonorgestrel is a compound classified as a Progesterone Congener, used to palliate symptoms of Polycystic Ovary Syndrome.\",1\n311,METFORMIN,\"Metformin is a compound classified as a Biguanide, used to treat Polycystic Ovary Syndrome.\",1\n309,NORETHINDRONE,\"Norethindrone is a compound classified as a Progesterone Congener, used to palliate symptoms of Polycystic Ovary Syndrome.\",1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\n373,ASTHENIA,OSTEOPOROSIS,\"Osteoporosis presents asthenia as a symptom, indicating a lack of energy and strength\",44\n688,DOXORUBICIN,SARCOMA,\"Doxorubicin is used to treat Sarcoma, indicating a direct therapeutic relationship\",44\n427,ETOPOSIDE,VAGINAL CANCER,Etoposide can treat Vaginal Cancer,42\n790,OSTEOPOROSIS,RALOXIFENE,\"Osteoporosis is a condition characterized by weakened bones, increasing the risk of fractures. Raloxifene is a medication specifically used to treat osteoporosis. While effective in managing this condition, Raloxifene is associated with various side effects.\",42\n434,ETHINYL ESTRADIOL,OSTEOPOROSIS,\"Ethinyl estradiol is used to treat osteoporosis, with several side effects\",41\n437,CONJUGATED ESTROGENS,OSTEOPOROSIS,\"Conjugated estrogens are used to treat osteoporosis, with several side effects\",40\n421,EPIRUBICIN,STOMACH CANCER,Epirubicin is a compound that treats Stomach Cancer,40\n429,ETOPOSIDE,URINARY BLADDER CANCER,Etoposide is a compound used to treat Urinary Bladder Cancer,40\n280,PROSTATE CANCER,NILUTAMIDE,Nilutamide is used to treat Prostate Cancer,40\n235,EDEMA,OSTEOPOROSIS,\"Osteoporosis may present edema as a symptom, indicating fluid retention\",40\n390,ANOREXIA,SARCOMA,\"Anorexia is a symptom of Sarcoma, indicating a direct relationship between the disease and the symptom\",40\n428,ETOPOSIDE,SARCOMA,\"Etoposide is used to treat Sarcoma, indicating a direct therapeutic relationship\",39\n551,BODY WEIGHT,OSTEOPOROSIS,\"Osteoporosis can affect body weight, leading to changes in health and mobility\",39\n422,EPIRUBICIN,SARCOMA,\"Epirubicin is used to treat Sarcoma, indicating a direct therapeutic relationship\",38\n440,MITOXANTRONE,SARCOMA,\"Mitoxantrone is used to treat Sarcoma, indicating a direct therapeutic relationship\",38\n306,LYMPH NODE,SARCOMA,\"Sarcoma can localize in lymph nodes, indicating a relationship between the disease and the body part\",38\n552,BODY WEIGHT,SARCOMA,\"Changes in body weight are symptoms of Sarcoma, indicating a direct relationship between the disease and the symptom\",36\n298,PAIN,OSTEOPOROSIS,Pain is a common symptom associated with osteoporosis,35\n392,BACK PAIN,OSTEOPOROSIS,Osteoporosis often leads to back pain due to fractures or spinal changes,34\n169,UTERUS,OSTEOPOROSIS,\"Osteoporosis can impact the uterus, particularly in postmenopausal women\",34\n238,MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE,OSTEOPOROSIS,Monoclonal Gammopathy can be associated with osteoporosis,33\n480,MUSCULAR ATROPHY,OSTEOPOROSIS,Osteoporosis can lead to muscular atrophy due to decreased mobility,33\n283,ANOXIA,SARCOMA,\"Anoxia is a symptom of Sarcoma, indicating a direct relationship between the disease and the symptom\",33\n452,CHEST PAIN,SARCOMA,\"Chest pain is a symptom of Sarcoma, indicating a direct relationship between the disease and the symptom\",33\n548,ABDOMEN,SARCOMA,\"Sarcoma presents symptoms in the abdomen, indicating a relationship between the disease and the body part\",33\n787,OSTEOPOROSIS,ALENDRONATE,\"Alendronate is a treatment for osteoporosis, associated with various side effects\",32\n788,OSTEOPOROSIS,CALCIUM ACETATE,\"Calcium acetate is used to treat osteoporosis, with various side effects\",32\n784,OSTEOPOROSIS,CHOLECALCIFEROL,Cholecalciferol is used to treat osteoporosis by promoting calcium absorption,32\n770,OSTEOPOROSIS,EMACIATION,\"Osteoporosis can lead to emaciation, reflecting severe weight loss\",32\n776,OSTEOPOROSIS,EPIPHYSIS,\"The epiphysis can be affected by osteoporosis, particularly in joint areas\",32\n789,OSTEOPOROSIS,ESTROPIPATE,\"Estropipate is used to treat osteoporosis, with several side effects\",32\n771,OSTEOPOROSIS,HEMIPLEGIA,\"In severe cases, osteoporosis can lead to hemiplegia due to complications\",32\n777,OSTEOPOROSIS,HIP,The hip is a common site for fractures in osteoporosis patients,32\n778,OSTEOPOROSIS,HIP JOINT,\"The hip joint is critical in osteoporosis, often leading to fractures\",32\n786,OSTEOPOROSIS,IBANDRONATE,\"Ibandronate is used to treat osteoporosis, with side effects\",32\n780,OSTEOPOROSIS,JAW SKELETON,The jaw skeleton may be impacted by osteoporosis,32\n781,OSTEOPOROSIS,LOWER JAW REGION,The lower jaw region can be affected by osteoporosis,32\n779,OSTEOPOROSIS,MANDIBLE,\"The mandible can be affected by osteoporosis, impacting dental health\",32\n772,OSTEOPOROSIS,MENKES KINKY HAIR SYNDROME,Menkes Kinky Hair Syndrome may present symptoms similar to osteoporosis,32\n773,OSTEOPOROSIS,VERTEBRAL COLUMN,\"Osteoporosis significantly affects the vertebral column, leading to fractures\",32\n774,OSTEOPOROSIS,PARATHYROID GLAND,The parathyroid gland's function can be affected by osteoporosis,32\n775,OSTEOPOROSIS,SCIATIC NERVE,Osteoporosis-related conditions can impact the sciatic nerve,32\n782,OSTEOPOROSIS,OXANDROLONE,\"Oxandrolone is used to palliate osteoporosis, though it has side effects\",32\n783,OSTEOPOROSIS,ZOLEDRONATE,\"Zoledronate is used to treat osteoporosis, associated with various side effects\",32\n785,OSTEOPOROSIS,RISEDRONATE,\"Risedronate is a treatment for osteoporosis, associated with various side effects\",32\n318,TESTIS,SARCOMA,\"Sarcoma can localize in the testis, indicating a relationship between the disease and the body part\",32\n577,ACUTE,SARCOMA,\"Acute is a symptom of Sarcoma, indicating a direct relationship between the disease and the symptom\",32\n393,BACK PAIN,SARCOMA,\"Back pain is a symptom of Sarcoma, indicating a direct relationship between the disease and the symptom\",31\n170,UTERUS,SARCOMA,\"Sarcoma can localize in the uterus, indicating a relationship between the disease and the body part\",31\n321,SEMINAL VESICLE,SARCOMA,\"Sarcoma can localize in the seminal vesicle, indicating a relationship between the disease and the body part\",31\n596,DIPLOPIA,SARCOMA,\"Diplopia is a symptom of Sarcoma, indicating a direct relationship between the disease and the symptom\",31\n624,DYSPNEA,SARCOMA,\"Dyspnea is a symptom of Sarcoma, indicating a direct relationship between the disease and the symptom\",31\n795,THIOTEPA,URINARY BLADDER CANCER,Thiotepa is a compound used to treat Urinary Bladder Cancer,31\n792,SARCOMA,THIOTEPA,\"Thiotepa is used to treat Sarcoma, indicating a direct therapeutic relationship\",30\n40,LEG,SARCOMA,\"Sarcoma can localize in the leg, indicating a relationship between the disease and the body part\",30\n168,EMBRYO,SARCOMA,\"Sarcoma can localize in the embryo, indicating a relationship between the disease and the body part\",30\n455,COUGH,SARCOMA,\"Cough is a symptom of Sarcoma, indicating a direct relationship between the disease and the symptom\",30\n483,TENDON,SARCOMA,\"Sarcoma can localize in tendons, indicating a relationship between the disease and the body part\",30\n682,CACHEXIA,SARCOMA,\"Cachexia is a severe symptom of Sarcoma, indicating a direct relationship between the disease and the symptom\",30\n718,VINCRISTINE,SARCOMA,\"Vincristine is used to treat Sarcoma, indicating a direct therapeutic relationship\",30\n768,DACARBAZINE,SARCOMA,\"Dacarbazine is used to treat Sarcoma, indicating a direct therapeutic relationship\",30\n791,SARCOMA,DACTINOMYCIN,\"Dactinomycin is used to treat Sarcoma, indicating a direct therapeutic relationship\",29\n143,ABDOMINAL PAIN,NILUTAMIDE,Nilutamide can cause abdominal pain as a side effect,29\n794,SARCOMA,PLEURA,\"Sarcoma can localize in the pleura, indicating a relationship between the disease and the body part\",29\n793,SARCOMA,STERNUM,\"Sarcoma can localize in the sternum, indicating a relationship between the disease and the body part\",29\n439,MITOXANTRONE,LYMPHATIC SYSTEM CANCER,Mitoxantrone is used to treat Lymphatic System Cancer,24\n416,EPIRUBICIN,ETOPOSIDE,\"Both Epirubicin and Etoposide are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",21\n423,ETOPOSIDE,ETHINYL ESTRADIOL,\"Both Etoposide and Ethinyl Estradiol are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",21\n426,ETOPOSIDE,MITOXANTRONE,\"Both Etoposide and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",21\n343,NILUTAMIDE,ETOPOSIDE,\"Both Nilutamide and Etoposide are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",21\n424,ETOPOSIDE,CONJUGATED ESTROGENS,\"Both Etoposide and Conjugated Estrogens are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",20\n417,EPIRUBICIN,ETHINYL ESTRADIOL,\"Both Epirubicin and Ethinyl Estradiol are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",20\n420,EPIRUBICIN,MITOXANTRONE,\"Both Epirubicin and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",20\n342,NILUTAMIDE,EPIRUBICIN,\"Both Nilutamide and Epirubicin are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",20\n432,ETHINYL ESTRADIOL,MITOXANTRONE,\"Both Ethinyl Estradiol and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",20\n344,NILUTAMIDE,ETHINYL ESTRADIOL,\"Both Nilutamide and Ethinyl Estradiol are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",20\n347,NILUTAMIDE,MITOXANTRONE,\"Both Nilutamide and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",20\n425,ETOPOSIDE,ABIRATERONE,\"Both Etoposide and Abiraterone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",19\n436,CONJUGATED ESTROGENS,MITOXANTRONE,\"Both Conjugated Estrogens and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",19\n345,NILUTAMIDE,CONJUGATED ESTROGENS,\"Both Nilutamide and Conjugated Estrogens are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",19\n418,EPIRUBICIN,CONJUGATED ESTROGENS,\"Both Epirubicin and Conjugated Estrogens are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",19\n430,ETHINYL ESTRADIOL,CONJUGATED ESTROGENS,\"Both Ethinyl Estradiol and Conjugated Estrogens are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",19\n405,ESTRADIOL,ETOPOSIDE,\"Both Estradiol and Etoposide are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",19\n411,PREDNISONE,ETOPOSIDE,\"Both Prednisone and Etoposide are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",19\n438,ABIRATERONE,MITOXANTRONE,\"Both Abiraterone and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n346,NILUTAMIDE,ABIRATERONE,\"Both Nilutamide and Abiraterone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n419,EPIRUBICIN,ABIRATERONE,\"Both Epirubicin and Abiraterone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n431,ETHINYL ESTRADIOL,ABIRATERONE,\"Both Ethinyl Estradiol and Abiraterone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n404,ESTRADIOL,EPIRUBICIN,\"Both Estradiol and Epirubicin are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n410,PREDNISONE,EPIRUBICIN,\"Both Prednisone and Epirubicin are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n406,ESTRADIOL,ETHINYL ESTRADIOL,\"Both Estradiol and Ethinyl Estradiol are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n409,ESTRADIOL,MITOXANTRONE,\"Both Estradiol and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n340,NILUTAMIDE,ESTRADIOL,\"Both Nilutamide and Estradiol are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n412,PREDNISONE,ETHINYL ESTRADIOL,\"Both Prednisone and Ethinyl Estradiol are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n415,PREDNISONE,MITOXANTRONE,\"Both Prednisone and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n341,NILUTAMIDE,PREDNISONE,\"Both Nilutamide and Prednisone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n435,CONJUGATED ESTROGENS,ABIRATERONE,\"Both Conjugated Estrogens and Abiraterone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",17\n407,ESTRADIOL,CONJUGATED ESTROGENS,\"Both Estradiol and Conjugated Estrogens are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",17\n413,PREDNISONE,CONJUGATED ESTROGENS,\"Both Prednisone and Conjugated Estrogens are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",17\n408,ESTRADIOL,ABIRATERONE,\"Both Estradiol and Abiraterone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",16\n414,PREDNISONE,ABIRATERONE,\"Both Prednisone and Abiraterone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",16\n403,ESTRADIOL,PREDNISONE,\"Both Estradiol and Prednisone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",16\n433,ETHINYL ESTRADIOL,POLYCYSTIC OVARY SYNDROME,Ethinyl Estradiol is used to palliate symptoms of Polycystic Ovary Syndrome,16\n710,LYMPHATIC SYSTEM CANCER,VINCRISTINE,Vincristine is used to treat Lymphatic System Cancer,16\n394,BACK PAIN,ISRADIPINE,\"Back pain is a side effect of Isradipine, indicating a direct relationship between the compound and the side effect.\",13\n650,POLYCYSTIC OVARY SYNDROME,DESOGESTREL,Desogestrel is used to palliate symptoms of Polycystic Ovary Syndrome,7\n648,POLYCYSTIC OVARY SYNDROME,DROSPIRINONE,Drospirenone is used to palliate symptoms of Polycystic Ovary Syndrome,7\n647,POLYCYSTIC OVARY SYNDROME,LEVONORGESTREL,Levonorgestrel is used to palliate symptoms of Polycystic Ovary Syndrome,7\n651,POLYCYSTIC OVARY SYNDROME,METFORMIN,Metformin is used to treat Polycystic Ovary Syndrome,7\n649,POLYCYSTIC OVARY SYNDROME,NORETHINDRONE,Norethindrone is used to palliate symptoms of Polycystic Ovary Syndrome,7\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}